Embark sponsors The National Dog Show, in commitment to improving life and longevity of all dogs November 16, 2021
FDA Grants AppliedVR Approval for First Virtual Reality Therapeutic to Treat Chronic Low Back Pain November 16, 2021
Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology November 14, 2021
Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer November 12, 2021
AppliedVR Raises $36 Million Series B To Scale Comprehensive Virtual Reality Platform For Healthcare November 11, 2021
Innovent Publishes the Preclinical Results of IBI319 (Anti PD-1/CD137 Bispecific Antibody) in Nature Communications November 7, 2021
Avidity Announces First Person Dosed with an Antibody Oligonucleotide Conjugate (AOC™) November 4, 2021